Precision Therapeutics Inc. Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Consulting Agreements (2)
- Employment Agreements (13)
- Non-Competition Agreements (1)
- Separation Agreements (3)
- Employment Agreement dated February 23, 2023 by and between Pamela Bush and Predictive Oncology Inc (Filed With SEC on February 28, 2023)
- Employment Agreement dated effective November 1, 2022 by and between Raymond F. Vennare and Predictive Oncology Inc (Filed With SEC on October 20, 2022)
- Employment Offer Letter dated September 30, 2022 by and between Raymond F. Vennare and Predictive Oncology Inc (Filed With SEC on October 20, 2022)
- Transition and Separation Agreement dated September 15, 2022 by and between J. Melville Engle and Predictive Oncology Inc (Filed With SEC on September 16, 2022)
- Amended and Restated Employment Agreement, effective as of August 1, 2022, by and between Julia Kirshner and Predictive Oncology Inc (Filed With SEC on July 26, 2022)
- Form of Stock Option Agreement for Directors under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)
- Form of Stock Option Agreement for Executive Officers under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)
- Form of Stock Option Agreement for Employees under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)
- 2021 Long Term Incentive Plan (Filed With SEC on May 20, 2021)
- Employment Agreement by and between the Company and J. Melville Engle dated effective as of March 19, 2021 (Filed With SEC on April 7, 2021)
- Transition and Separation Agreement by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)
- Form of Amended and Restated Employment Agreement with Carl Schwartz (Filed With SEC on August 19, 2019)
- Consulting Agreement dated effective as of May 1, 2019 by and between the Company and Richard Gabriel (Filed With SEC on May 8, 2019)
- Amendment to Employment Agreement by and between the Issuer and Bob Myers dated August 20, 2018 (Filed With SEC on April 1, 2019)
- Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 22, 2019)
- Consulting Agreement dated effective as of April 1, 2018 by and between the Company and Richard Gabriel (Filed With SEC on April 4, 2018)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 17, 2016)
- BIODRAINMEDICAL, INC. 2012 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD GRANT (Filed With SEC on June 18, 2013)
- AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 18, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2012)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2012)
- AMENDMENT NO. 1 TO BIODRAIN MEDICAL, INC. 2008 EQUITY INCENTIVE PLAN (Filed With SEC on June 15, 2011)
- AMENDMENTNO. 1 TO BIODRAINMEDICAL, INC. 2008 EQUITY INCENTIVE PLAN (Filed With SEC on June 23, 2010)
- (DATE)September 11, 2008 AMENDMENTTO EMPLOYMENT AGREEMENT (Filed With SEC on January 12, 2009)
- BioDrain Medical, Inc. (A Minnesota Corporation) 2008 Equity Incentive Plan October 31, 2008 (Filed With SEC on November 12, 2008)
- Exhibit A NONDISCLOSURE AND NONCOMPETE AGREEMENT (Filed With SEC on November 12, 2008)